By
MikeH on
March 19, 2013
Snuggled up in my bed under the warm covers, all I want to do is keep my eyes closed.
But, no. My darn insulin pump and continuous glucose monitor (CGM) just won’t shut up and let me sleep. Both vibrate and beep incessantly, reminding me that I’m low and nagging me to wake up and do something about it.
Neither device can actually intervene or do anything to prevent these lows (or highs) from happening.…
Read more »
By
AmyT on
December 9, 2011
In the last few years, we’ve seen a few sleeker-looking glucose meters make it to market, along with more logging tools and apps than we can shake a stick at. But what’s still been lacking is some good assistance in taking all those numbers and actually knowing what to do with them — what changes do they call for in our diabetes management?
Unless you’re telephoning your CDE or endo every time you spot some…
Read more »
By
AmyT on
February 22, 2011
This week, J&J’s Animas is recalling a batch of 45,000 faulty insulin cartridges shipped between Nov. 30, 2010, and Jan. 4, 2011, that reportedly can leak insulin, resulting in the delivery of less insulin than intended. Note that the pump most likely will not alarm if there is an internal leak. If you are affected by this, you should be receiving an email and a letter from the company shortly, in addition to a set…
Read more »
By
AmyT on
January 6, 2010
What went through your mind when you heard about the sudden death of Johnson & Johnson heiress Casey Johnson a few days ago? I can’t imagine a Type 1 diabetic out there who isn’t shuddering in their shoes. She was only 30 years old, for goodness’ sake, and despite the drugs and alcohol, she’d likely be alive today if her diabetes hadn’t played some role.
There’s been a ton of speculation since Casey, a prominent…
Read more »
By
AmyT on
January 5, 2010
At the end of last year (so, basically, two weeks ago), the Juvenile Diabetes Research Foundation announced a joint partnership with the Johnson & Johnson Corporate Office of Science and Technology to help with the discovery and development of drugs to promote beta cell survival. The program will look to fund research at academic centers around the world that could eventually lead to novel new drugs for the prevention and treatment of type 1 diabetes.
Sounds…
Read more »